Correlation between body mass index and clinicopathological features of papillary thyroid microcarcinoma.
نویسندگان
چکیده
OBJECTIVES To demonstrate the relationships between body mass index (BMI) and the clinicopathological features of papillary thyroid microcarcinoma (PTMC) and papillary thyroid carcinoma (PTC). METHODS A total of 810 consecutive patients with PTC (501 patients with PTMC) who underwent total thyroidectomy in 2009-2013 were retrospectively reviewed. Height and weight were used to calculate BMI. RESULTS Increased BMI was strongly associated with i) extrathyroidal invasion (P < 0.001) and advanced TNM stage (P = 0.005) in patients with PTMC (n = 501), and ii) extrathyroidal invasion (P = 0.001), advanced TNM stage (P = 0.001), and multifocality (P = 0.002) in patients with PTC (n = 810). As compared with normal-weight patients with PTMC, obese patients with PTMC had greater risks of extrathyroidal invasion (OR = 5.214, P = 0.0270), and overweight patients with PTMC had greater risks of extrathyroidal invasion (OR = 2.165, P = 0.0013) and advanced TNM stage (OR = 2.019, P = 0.0137). As compared with normal-weight patients with PTC, obese patients with PTC had greater risks of extrathyroidal invasion (OR = 3.101, P = 0.0172), and overweight patients with PTC had greater risks of extrathyroidal invasion (OR = 1.486, P = 0.0279), advanced TNM stage (OR = 1.650, P = 0.0347), and multifocality (OR = 1.651, P = 0.0054). CONCLUSIONS Increased BMI might elevate the risks of aggressive clinicopathological features, such as extrathyroidal invasion and advanced TNM stage. Obesity control may play an important role in preventing the development of aggressive PTMCs and all PTCs.
منابع مشابه
Thyroid Papillary Microcarcinoma: Etiology, Clinical Manifestations, Diagnosis, Follow-up, Histopathology and Prognosis
Background: Thyroid carcinoma is the most common malignancy of the endocrine system. Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer, accounting for 70–90% of well-differentiated thyroid malignancies. Thyroid papillary microcarcinoma is a subtype of papillary carcinoma that included tumors with less than 10mm diameter. As a result of diagnostic methods improvement, p...
متن کاملIs familial papillary thyroid microcarcinoma more aggressive than sporadic form?
PURPOSE With the increasing incidence of papillary thyroid microcarcinoma (PTMC), familial papillary thyroid microcarcinoma (FPTMC) is now recognized more frequently. However, the biological behavior of FPTMC is poorly understood. The aim of this study was to investigate the prevalence of FPTMC and its biological aggressiveness. METHODS Between March 2006 and July 2010, 2,414 patients underwe...
متن کاملPapillary microcarcinoma in comparison with larger papillary thyroid carcinoma in BRAF(V600E) mutation, clinicopathological features, and immunohistochemical findings.
BACKGROUND Papillary thyroid microcarcinoma (PMC; <or=1 cm) is thought to take a benign course during the lifetime. However, recent studies showed high recurrence rates for PMC. METHODS We analyzed the clinicopathological features, long-term prognosis, and some molecular characteristics including BRAF(V600E) mutation by retrospectively reviewing the records of 1150 patients with papillary thy...
متن کاملDetection of Tumor Multifocality Is Important for Prediction of Tumor Recurrence in Papillary Thyroid Microcarcinoma: A Retrospective Study and Meta-Analysis
BACKGROUND The clinicopathological characteristics and conclusive treatment modality for multifocal papillary thyroid microcarcinoma (mPTMC) have not been fully established. METHODS A retrospective study, systematic review, and meta-analysis were conducted to elucidate the clinicopathological significance of mPTMC. We investigated the multiplicity of 383 classical papillary thyroid microcarci...
متن کاملAssociation between BRAFV600E mutation and the clinicopathological features of solitary papillary thyroid microcarcinoma
The B-Raf proto-oncogene serine/threonine kinase (BRAF)V600E mutation is an important oncogene in the development of papillary thyroid carcinoma (PTC) and has been identified as a risk factor for poor prognosis in patients with PTC. However, whether the BRAFV600E mutation is a prognostic marker in patients with solitary papillary thyroid microcarcinoma (sPTMC) has not yet been established. The ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- International journal of clinical and experimental medicine
دوره 8 9 شماره
صفحات -
تاریخ انتشار 2015